Nature Reviews Clinical Oncology | 2019
Phase I trials as therapeutic options: (usually) a betrayal of evidence-based medicine
Abstract
Many argue that phase I cancer trials are a therapeutic option for eligible patients. I question this position and offer a more nuanced view that differentiates between types of trials. Patients seeking treatment might legitimately pursue phase I trials, although labelling all phase I trials as therapeutic contradicts the spirit of evidence-based medicine.